加捷生醫 (4109)
加捷生醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$49.90M, up 38.1% from a year earlier. EPS over the last four quarters totals NT$0.03.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2002-08-08
- Founded
- 1995-05-06
- Paid-in capital
- NT$1.19B
- Common shares issued
- 118,736,681
- Legal name
- 加捷生醫股份有限公司
- Website
- https://www.jiajiebio.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$49.90M | +13.2% | +38.1% |
| 2026-08 | NT$44.07M | -9.6% | +13.9% |
Year to date: +16.9% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.44 |
| 2026 Q1 | 0.15 |
| 2025 Q4 | 0.23 |
| 2025 Q3 | 0.09 |
| 2025 Q2 | -0.01 |
| 2025 Q1 | 0.12 |
| 2024 Q4 | -0.20 |
| 2024 Q3 | 0.01 |
Last four quarters: NT$0.03
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.20 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 35,795 | 0.7% |
| 1,000–5,000 shares | 5,565 | 9.8% |
| 5,001–10,000 shares | 1,005 | 6.5% |
| 10,001–15,000 shares | 383 | 4.0% |
| 15,001–20,000 shares | 224 | 3.4% |
| 20,001–30,000 shares | 210 | 4.4% |
| 30,001–40,000 shares | 91 | 2.7% |
| 40,001–50,000 shares | 62 | 2.4% |
| 50,001–100,000 shares | 134 | 8.0% |
| 100,001–200,000 shares | 68 | 8.1% |
| 200,001–400,000 shares | 25 | 5.7% |
| 400,001–600,000 shares | 11 | 4.8% |
| 600,001–800,000 shares | 3 | 1.6% |
| 800,001–1,000,000 shares | 2 | 1.5% |
| 1,000,001+ shares | 13 | 36.3% |
TDCC data for 2026-10-16: 13 holders own more than 1,000 lots (36.3% of shares), and 35,795 hold less than one lot (0.7%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 13 | 0 | 0 | 13 |
| 2026-10-16 | -4 | 0 | 0 | -4 |
| 2026-10-15 | 64 | 0 | 0 | 64 |
| 2026-10-14 | 13 | 0 | 0 | 13 |
| 2026-10-13 | 7 | 0 | 0 | 7 |
| 2026-10-12 | 6 | 0 | 0 | 6 |
| 2026-10-08 | 5 | 0 | 1 | 6 |
| 2026-10-07 | 3 | 0 | 0 | 3 |
| 2026-10-06 | 1 | 0 | 0 | 1 |
| 2026-10-05 | -9 | 0 | 0 | -9 |
| 2026-10-02 | 5 | 0 | 0 | 5 |
| 2026-10-01 | 32 | 0 | 0 | 32 |
| 2026-09-30 | 7 | 0 | 0 | 7 |
| 2026-09-29 | 9 | 0 | 0 | 9 |
| 2026-09-24 | -4 | 0 | 0 | -4 |
| 2026-09-23 | -4 | 0 | -1 | -5 |
| 2026-09-22 | 3 | 0 | 1 | 4 |
| 2026-09-21 | 2 | 0 | 0 | 2 |
| 2026-09-18 | 11 | 0 | 0 | 11 |
| 2026-09-17 | -12 | 0 | 0 | -12 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 149 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$11.00 (2026-10-19); 52-week range NT$10.35–16.90.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.